OVARIAN CANCER and US

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, December 06, 2009

Unanticipated toxicities from anticancer therapies: Survivors’ perspectives



What are Platelets? Thrombotic Thrombocytopenic Purpura Hemolytic Uremic Syndrome (TTP-HUS)



“Platelets: Too Many, Too Few” Session is Just Right



“Platelets: Too Many, Too Few” Session is Just Right

NEJM -- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism



The Impact of Complete Surgical Staging Upon Survival in Early-Stage Ovarian Clear Cell Carcinoma: A Multi-institutional Retrospective Study



Although the study was a limited retrospective study, the impact of peritoneal cytology status was more important than complete surgical staging procedure in CCC patients. More effective treatment modality was warranted, especially for CCC cases positive for malignant peritoneal cytology.

Preoperative CA-125 Levels in 123 Patients With Borderline Ovarian Tumors: A Retrospective Analysis and Review of the Literature



From a clinical perspective, we believe, on base of the results of this study and the literature, that preoperative discrimination using CA-125 level is especially difficult between patients with stage I ovarian cancer and the group of patients with serous and/or advanced-stage BOTs.

Expression of p53 Protein Phosphorylated at Serine 20 and Serine 392 in Malignant and Benign Ovarian Neoplasms: Correlation With Clinicopathological P



Risk of Hospitalizations Associated With Adverse Effects of Chemotherapy in a Large Community-Based Cohort of Elderly Women With Ovarian Cancer



Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?



2007 A systematic review of studies comparing health outcomes in Canada and the United States | Guyatt | Array



A systematic review of studies comparing health outcomes in Canada and the United States | Guyatt | Array

Saturday, December 05, 2009

This test can spare women from chemo. But they can't get it here - The Globe and Mail



This test can spare women from chemo. But they can't get it here - The Globe and Mail

My response: some of the public's opinions which, as usual, were way off target to the original focus of the article: It's always a great transformation of opinion when those without a cancer diagnosis are diagnosed. It's very nice to know there are so many who believe in each paying for their own healthcare except...that's nice. But, envision your neighbour, your family member, your friend who cannot. Envision if it is your neighbour's child. Nice that we seem to have come to such a one-person self-centerness that we cannot see beyond the small picture of one.

Questioning a Cancer Drug That Costs $30,000 a Month - NYTimes.com



Questioning a Cancer Drug That Costs $30,000 a Month - NYTimes.com

2009 Cochrane review: Opioids for the management of breakthrough (episodic) pain in cancer patients



Opioids for the management of breakthrough (episodic) pain in cancer patients

Response: Does Morphine Stimulate Cancer Growth? | GeriPal - A Geriatrics and Palliative Care Blog



Does Morphine Stimulate Cancer Growth? | GeriPal - A Geriatrics and Palliative Care Blog

Response to the dialogues:
Sandi Pniauskas said...

While the media and pharma are often criticized in situations such as this, there is the communication factor - good or bad. The value to patients of harm vs benefit is that the information is available and sufficient enough for patients to question, research and also take the information for discussion to their professional caregivers. The e-patient communities welcome dialogues but not in an exclusive setting which is absent their participation.

Neurontin: PRC: Journals Aided in Marketing of Gabapentin - in Meeting Coverage, PRC from MedPage Today



Medical News: PRC: Journals Aided in Marketing of Gabapentin - in Meeting Coverage, PRC from MedPage Today

Medical News: PRC: Study Finds Less Ghost Authorship, Critics Ask Why - in Meeting Coverage, PRC from MedPage Today



Medical News: PRC: Study Finds Less Ghost Authorship, Critics Ask Why - in Meeting Coverage, PRC from MedPage Today

Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer




Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.



The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: A multicenter retrospective Italian study.